{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ01778",
      "entity_text" : "anti-tau antibodies",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:9606" ],
      "TissueType" : [ "tissuelist:TS-0095" ],
      "Organ" : [ "uberon:UBERON:0000468" ],
      "CellType" : [ "cl:CL:0000540" ]
    }
  },
  "verbose_text" : "Indeed, high levels of anti-tau antibodies, administered intra-ventricularly via minipumps, have shown a pronounced effect on tau pathology development in an AD like animal model, suggesting that selective targeting of extracellular tau in the brain has an impact on tau pathology development.",
  "reading_complete" : "2020-08-05T21:07:09Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-05T21:04:17Z",
  "trigger" : "levels",
  "evidence" : [ "levels of anti-tau antibodies" ],
  "pmc_id" : "6370742",
  "score" : 0
}